Japan city Tokyo vaccine DNA Coronavirus Japan city Tokyo

coronavirus vaccine: This biopharma venture surged almost 400% in 2-month

Reading now: 974
www.livemint.com

Thanks to a steady stream of subsequent announcements and tie-up partners and a 25% gain today, the stock of AnGes Inc. now commands the highest weighting of almost 10% on the $55 billion Tokyo Stock Exchange Mothers startup board TOKYO : A Japanese biopharma venture has surged almost 400% in just over two months on hopes that its vaccine candidate for the coronavirus will be successful.

AnGes Inc., a spin-off from Osaka University, announced March 5 that it was developing a DNA vaccine for coronavirus. Thanks to a steady stream of subsequent announcements and tie-up partners and a 25% gain on Thursday, the stock now commands the highest weighting of almost 10% on the 5.88 trillion yen ($55 billion) Tokyo Stock Exchange Mothers startup

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA